Tag Archives: Plaque

Lilly’s Taltz (ixekizumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis

Print this page INDIANAPOLIS, March 30, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) for Taltz (ixekizumab) injection, 80 mg/mL for the treatment of pediatric patients (ages 6 to under 18) with moderate to severe plaque psoriasis… Read More »

FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis

FDA Approves Skyrizi (risankizumab-rzaa) for Moderate to Severe Plaque Psoriasis Print this page NORTH CHICAGO, Ill., April 23, 2019 /PRNewswire/ — AbbVie today announced that the U.S. Food and Drug Administration (FDA) approved Skyrizi (risankizumab-rzaa), an interleukin-23 (IL-23) inhibitor, for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic… Read More »

Listerine Cool Mint Antiseptic Mouthwash for Bad Breath, Plaque and Gingivitis, 500 ml

Protect your mouth from germs and get fresh breath with Listerine Cool Mint Antiseptic Mouthwash. It kills 99.9% of germs that cause bad breath, plaque and gingivitis, for a fresher and cleaner mouth than brushing alone. Accepted by the American Dental Association, this germ-killing mouthwash is clinically shown to reduce plaque 52 percent more and… Read More »